176 related articles for article (PubMed ID: 1634536)
1. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14974-81. PubMed ID: 1634536
[TBL] [Abstract][Full Text] [Related]
2. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. I. Specificity of thrombin labeling.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14963-73. PubMed ID: 1634535
[TBL] [Abstract][Full Text] [Related]
3. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
Bock PE
Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
[TBL] [Abstract][Full Text] [Related]
4. Biotin derivatives of D-Phe-Pro-Arg-CH2Cl for active-site-specific labeling of thrombin and other serine proteinases.
Anderson PJ; Bock PE
Anal Biochem; 2001 Sep; 296(2):254-61. PubMed ID: 11554721
[TBL] [Abstract][Full Text] [Related]
5. Analogs of human plasminogen that are labeled with fluorescence probes at the catalytic site of the zymogen. Preparation, characterization, and interaction with streptokinase.
Bock PE; Day DE; Verhamme IM; Bernardo MM; Olson ST; Shore JD
J Biol Chem; 1996 Jan; 271(2):1072-80. PubMed ID: 8557633
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
Odake S; Kam CM; Powers JC
J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
[TBL] [Abstract][Full Text] [Related]
7. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
8. Evidence that meizothrombin is an intermediate product in the clotting of whole blood.
Bovill EG; Tracy RP; Hayes TE; Jenny RJ; Bhushan FH; Mann KG
Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):754-8. PubMed ID: 7773729
[TBL] [Abstract][Full Text] [Related]
9. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
10. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin.
Anderson PJ; Bock PE
J Biol Chem; 2003 Nov; 278(45):44489-95. PubMed ID: 12939270
[TBL] [Abstract][Full Text] [Related]
11. Zymogen/enzyme discrimination using peptide chloromethyl ketones.
Williams EB; Krishnaswamy S; Mann KG
J Biol Chem; 1989 May; 264(13):7536-45. PubMed ID: 2708377
[TBL] [Abstract][Full Text] [Related]
12. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK.
Martin PD; Malkowski MG; Box J; Esmon CT; Edwards BF
Structure; 1997 Dec; 5(12):1681-93. PubMed ID: 9438869
[TBL] [Abstract][Full Text] [Related]
13. Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation.
Kroh HK; Tans G; Nicolaes GA; Rosing J; Bock PE
J Biol Chem; 2007 Jun; 282(22):16095-104. PubMed ID: 17430903
[TBL] [Abstract][Full Text] [Related]
14. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.
Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
Biochemistry; 1993 May; 32(18):4727-37. PubMed ID: 8387813
[TBL] [Abstract][Full Text] [Related]
15. Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin.
Anderson PJ; Nesset A; Bock PE
J Biol Chem; 2003 Nov; 278(45):44482-8. PubMed ID: 12939269
[TBL] [Abstract][Full Text] [Related]
16. Role of regulatory exosite I in binding of thrombin to human factor V, factor Va, factor Va subunits, and activation fragments.
Dharmawardana KR; Olson ST; Bock PE
J Biol Chem; 1999 Jun; 274(26):18635-43. PubMed ID: 10373475
[TBL] [Abstract][Full Text] [Related]
17. Exosite binding tethers the macromolecular substrate to the prothrombinase complex and directs cleavage at two spatially distinct sites.
Boskovic DS; Krishnaswamy S
J Biol Chem; 2000 Dec; 275(49):38561-70. PubMed ID: 10984491
[TBL] [Abstract][Full Text] [Related]
18. Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase.
Bianchini EP; Orcutt SJ; Panizzi P; Bock PE; Krishnaswamy S
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10099-104. PubMed ID: 16006504
[TBL] [Abstract][Full Text] [Related]
19. [Interaction of human thrombin I fragment, prethrombin I, and alpha-thrombin with tissue thromboplastin].
Timerbaev VN; Zubairov DM; Kiselev SV; Kirshin SV; Soboleva IV
Biokhimiia; 1992 Jan; 57(1):77-90. PubMed ID: 1391207
[TBL] [Abstract][Full Text] [Related]
20. Characterization of proexosite I on prothrombin.
Anderson PJ; Nesset A; Dharmawardana KR; Bock PE
J Biol Chem; 2000 Jun; 275(22):16428-34. PubMed ID: 10748007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
